T40.992A Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter

Name of the Condition

• Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter

Summary

This ICD code describes intentional self-harm poisoning resulting from the use of other psychodysleptics (hallucinogens). It applies to cases where deliberate exposure to these substances causes toxic effects, typically due to self-inflicted ingestion or administration. Psychodysleptics alter perception, mood, or consciousness, and their intentional poisoning can lead to acute physiological or psychological symptoms requiring immediate medical intervention.

Causes

Intentional self-harm poisoning may occur from deliberate ingestion of hallucinogens, such as mescaline, DMT, or other substances not classified elsewhere. It can result from intentional overdose, misuse, or self-administration with the intent to cause harm. Interactions with other substances may exacerbate toxicity in these cases.

Risk Factors

• History of substance use or misuse.
• Underlying mental health conditions.
• Access to hallucinogens.
• Prior self-harm behaviors.
• Social or environmental stressors.

Symptoms

• Hallucinations, altered perception, or sensory distortions.
• Anxiety, paranoia, or disorientation.
• Nausea, vomiting, or dizziness.
• Increased heart rate or blood pressure.
• Potential for severe psychological distress or agitation.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, patient history, and toxicology screening to confirm exposure to hallucinogens. Healthcare providers assess the intent of self-harm, document the initial encounter, and rule out other causes of poisoning or adverse effects. Physical examination and laboratory tests may support the diagnosis.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute symptoms, and addressing the underlying intent. Interventions may include supportive care, monitoring vital signs, and administration of antidotes or medications to counteract effects. Psychiatric evaluation and crisis intervention are critical components of care.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying mental health status. Follow-up care often involves psychiatric support, substance use counseling, and monitoring for recurrence. Long-term outcomes vary based on individual circumstances and access to ongoing care.

Complications

Potential complications include respiratory distress, cardiovascular instability, seizures, or prolonged psychological effects. Severe cases may result in organ damage or life-threatening conditions requiring intensive care.

Lifestyle & Prevention

Prevention strategies include securing substances, promoting mental health awareness, and providing access to support resources. Education on the risks of hallucinogen use and self-harm can help reduce incidence. Encouraging open communication with healthcare providers may facilitate early intervention.

When to Seek Professional Help

Seek immediate medical attention if self-harm with hallucinogens is suspected or confirmed. Symptoms such as severe agitation, altered consciousness, or physiological distress require urgent evaluation. Mental health support should be sought to address underlying issues.

Tips for Medical Coders

Document the intent of self-harm clearly, including any statements or behaviors indicating deliberate exposure. Ensure the initial encounter is accurately coded, as subsequent encounters use different codes. Verify substance identification and confirm the poisoning is attributed to other psychodysleptics not classified elsewhere.